Mingyan Shao

Beijing, 100029, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

Sphingolipid Metabolism in Obesity: Bidirectional Regulation and Comparative Perspectives on Plant Sphingolipids.

Sphingolipid Metabolism in Obesity: Bidirectional Regulation and Comparative Perspectives on Plant Sphingolipids.

Journal: Nutrients

Published: July 01, 2026

Comprehensive Quantification of Oligoasthenozoospermia Induced by Obesity, Reproductive Toxicants, and Their Combination in Rat Models.

Comprehensive Quantification of Oligoasthenozoospermia Induced by Obesity, Reproductive Toxicants, and Their Combination in Rat Models.

Journal: Andrology

Published: August 05, 2025

Corrigendum to "AlphaFold-based AI docking reveals AMPK/SIRT1-TFEB pathway modulation by traditional Chinese medicine in metabolic-associated fatty liver disease" [Pharmacol. Res. 18 (2025), 212:107617. doi: 10.1016/j.phrs.2025.107617].

Corrigendum to "AlphaFold-based AI docking reveals AMPK/SIRT1-TFEB pathway modulation by traditional Chinese medicine in metabolic-associated fatty liver disease" [Pharmacol. Res. 18 (2025), 212:107617. doi: 10.1016/j.phrs.2025.107617].

Journal: Pharmacological research

Published: March 23, 2025

AlphaFold-based AI docking reveals AMPK/SIRT1-TFEB pathway modulation by traditional Chinese medicine in metabolic-associated fatty liver disease.

AlphaFold-based AI docking reveals AMPK/SIRT1-TFEB pathway modulation by traditional Chinese medicine in metabolic-associated fatty liver disease.

Journal: Pharmacological research

Published: December 04, 2024

A decrease in Flavonifractor plautii and its product, phytosphingosine, predisposes individuals with phlegm-dampness constitution to metabolic disorders.

A decrease in Flavonifractor plautii and its product, phytosphingosine, predisposes individuals with phlegm-dampness constitution to metabolic disorders.

Journal: Cell discovery

Published: October 31, 2024

Sphingolipid metabolites involved in the pathogenesis of atherosclerosis: perspectives on sphingolipids in atherosclerosis.

Sphingolipid metabolites involved in the pathogenesis of atherosclerosis: perspectives on sphingolipids in atherosclerosis.

Journal: Cellular & molecular biology letters

Published: July 29, 2024

PPARs in atherosclerosis: The spatial and temporal features from mechanism to druggable targets.

PPARs in atherosclerosis: The spatial and temporal features from mechanism to druggable targets.

Journal: Journal of advanced research

Published: January 17, 2024

Activation of RXRα exerts cardioprotection through transcriptional upregulation of Ndufs4 in heart failure.

Activation of RXRα exerts cardioprotection through transcriptional upregulation of Ndufs4 in heart failure.

Journal: Science bulletin

Published: October 16, 2023

Neocryptotanshinone ameliorates insufficient energy production in heart failure by targeting retinoid X receptor alpha.

Neocryptotanshinone ameliorates insufficient energy production in heart failure by targeting retinoid X receptor alpha.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: March 31, 2023

A Pharmacological Review of Tanshinones, Naturally Occurring Monomers from Salvia miltiorrhiza for the Treatment of Cardiovascular Diseases.

A Pharmacological Review of Tanshinones, Naturally Occurring Monomers from Salvia miltiorrhiza for the Treatment of Cardiovascular Diseases.

Journal: Oxidative medicine and cellular longevity

Published: September 14, 2022

Neocryptotanshinone protects against myocardial ischemia-reperfusion injury by promoting autolysosome degradation of protein aggregates via the ERK1/2-Nrf2-LAMP2 pathway.

Neocryptotanshinone protects against myocardial ischemia-reperfusion injury by promoting autolysosome degradation of protein aggregates via the ERK1/2-Nrf2-LAMP2 pathway.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: July 21, 2022

Ginsenoside Rb3 upregulates sarcoplasmic reticulum Ca2+-ATPase expression and improves the contractility of cardiomyocytes by inhibiting the NF-κB pathway.

Ginsenoside Rb3 upregulates sarcoplasmic reticulum Ca2+-ATPase expression and improves the contractility of cardiomyocytes by inhibiting the NF-κB pathway.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: July 20, 2022

Showing 1-12 of 29

Last Updated: 09/26/2026